Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Sep 8, 2026, 4:00 PM EST
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $1.8 thousand as of September 9, 2026. Its market cap has decreased by -91.67% in one year.
Market Cap
1.80K
Enterprise Value
n/a
Revenue
17.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since June 18, 2021, Telesis Bio's market cap has decreased from 522.24M to 1.80K, a decrease of -100.00%. That is a compound annual growth rate of -90.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 1.80K | -98.00% |
| Dec 31, 2025 | 90.09K | -87.32% |
| Dec 31, 2024 | 710.34K | -94.06% |
| Dec 29, 2023 | 11.96M | -66.23% |
| Dec 30, 2022 | 35.43M | -88.81% |
| Dec 31, 2021 | 316.52M | -39.39% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acutus Medical | 2.99K |
| Forza Innovations | 2.65K |
| Viveve Medical | 2.15K |
| Urologix | 2.13K |
| ProUroCare Medical | 1.86K |
| Dynatronics | 1.61K |
| Southern Home Medical | 1.49K |
| Motus GI Holdings | 1.44K |